225 related articles for article (PubMed ID: 28003932)
1. Allogeneic Mesenchymal Stem Cell Transplantation in Dogs With Keratoconjunctivitis Sicca.
Bittencourt MK; Barros MA; Martins JF; Vasconcellos JP; Morais BP; Pompeia C; Bittencourt MD; Evangelho KD; Kerkis I; Wenceslau CV
Cell Med; 2016 Dec; 8(3):63-77. PubMed ID: 28003932
[TBL] [Abstract][Full Text] [Related]
2. Effect of cyclosporine on conjunctival mucin in a canine keratoconjunctivitis sicca model.
Moore CP; McHugh JB; Thorne JG; Phillips TE
Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):653-9. PubMed ID: 11222523
[TBL] [Abstract][Full Text] [Related]
3. Use of adipose-derived mesenchymal stem cells in keratoconjunctivitis sicca in a canine model.
Villatoro AJ; Fernández V; Claros S; Rico-Llanos GA; Becerra J; Andrades JA
Biomed Res Int; 2015; 2015():527926. PubMed ID: 25802852
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Periocular Fatty Acids and 0.15% Hyaluronate Eye Drops Application on Keratoconjunctivitis Sicca in Dogs: An Exploratory Study.
Amalfitano C; Pasolini MP; Nieddu A; Della Valle G; Fiorentin PG; Lamagna F; Lamagna B
Top Companion Anim Med; 2019 Jun; 35():18-25. PubMed ID: 31122683
[TBL] [Abstract][Full Text] [Related]
5. Systemic Treatment of Immune-Mediated Keratoconjunctivitis Sicca with Allogeneic Stem Cells Improves the Schirmer Tear Test Score in a Canine Spontaneous Model of Disease.
Hermida-Prieto M; García-Castro J; Mariñas-Pardo L
J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945277
[TBL] [Abstract][Full Text] [Related]
6. Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca.
Berdoulay A; English RV; Nadelstein B
Vet Ophthalmol; 2005; 8(4):225-32. PubMed ID: 16008701
[TBL] [Abstract][Full Text] [Related]
7. Assessment of tear film osmolarity using the IPen
Brito FLDC; Voitena JN; Marinho TOC; Moore BA; Montiani-Ferreira F
Vet Ophthalmol; 2022 May; 25(3):219-224. PubMed ID: 34929058
[TBL] [Abstract][Full Text] [Related]
8. Retrospective study of the prevalence of keratoconjunctivitis sicca in diabetic and nondiabetic dogs after phacoemulsification.
Gemensky-Metzler AJ; Sheahan JE; Rajala-Schultz PJ; Wilkie DA; Harrington J
Vet Ophthalmol; 2015 Nov; 18(6):472-80. PubMed ID: 25429857
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy of topical oclacitinib 0.1% and tacrolimus 0.01% in canine keratoconjunctivitis sicca.
de Oliveira JK; Williams DL; Bollmann C; de Seabra NM; Bortolini M; Montiani-Ferreira F
Vet Ophthalmol; 2019 Sep; 22(5):633-643. PubMed ID: 30724448
[TBL] [Abstract][Full Text] [Related]
10. Use of episcleral cyclosporine implants in dogs with keratoconjunctivitis sicca: pilot study.
Barachetti L; Rampazzo A; Mortellaro CM; Scevola S; Gilger BC
Vet Ophthalmol; 2015 May; 18(3):234-41. PubMed ID: 24799029
[TBL] [Abstract][Full Text] [Related]
11. Topical applications of allogeneic adipose-derived mesenchymal stem cells ameliorate the canine keratoconjunctivitis sicca.
Wei LN; Wu CH; Lin CT; Liu IH
BMC Vet Res; 2022 Jun; 18(1):217. PubMed ID: 35689226
[TBL] [Abstract][Full Text] [Related]
12. Tear ferning in normal dogs and dogs with keratoconjunctivitis sicca.
Williams D; Hewitt H
Open Vet J; 2017; 7(3):268-272. PubMed ID: 29038779
[TBL] [Abstract][Full Text] [Related]
13. Conjunctival effects of canine distemper virus-induced keratoconjunctivitis sicca.
de Almeida DE; Roveratti C; Brito FL; Godoy GS; Duque JC; Bechara GH; Laus JL
Vet Ophthalmol; 2009; 12(4):211-5. PubMed ID: 19604335
[TBL] [Abstract][Full Text] [Related]
14. Clinical-dosimetric relationship between lacrimal gland dose and keratoconjunctivitis sicca in dogs with sinonasal tumors treated with radiation therapy.
Poirier VJ; Matsuyama A; Kim C; Darko J; Fleck A
J Vet Intern Med; 2020 Mar; 34(2):867-872. PubMed ID: 32086981
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of corneal impression cytology in dogs and its application in the diagnosis of keratoconjunctivitis sicca.
Lejarza-Ilaro M; Rodriguez-Alvaro A; Sanchez-Maldonado B; Gonzalez-Alonso-Alegre E
Vet Rec; 2019 Jun; 184(22):678. PubMed ID: 31019006
[TBL] [Abstract][Full Text] [Related]
16. Infrared ocular thermography in dogs with and without keratoconjunctivitis sicca.
Biondi F; Dornbusch PT; Sampaio M; Montiani-Ferreira F
Vet Ophthalmol; 2015 Jan; 18(1):28-34. PubMed ID: 23905697
[TBL] [Abstract][Full Text] [Related]
17. Immune-mediated keratoconjunctivitis sicca in dogs: current perspectives on management.
Dodi PL
Vet Med (Auckl); 2015; 6():341-347. PubMed ID: 30101119
[TBL] [Abstract][Full Text] [Related]
18. Assessment of meibomian gland morphology by noncontact infrared meibography in Shih Tzu dogs with or without keratoconjunctivitis sicca.
Kitamura Y; Maehara S; Nakade T; Miwa Y; Arita R; Iwashita H; Saito A
Vet Ophthalmol; 2019 Nov; 22(6):744-750. PubMed ID: 30715776
[TBL] [Abstract][Full Text] [Related]
19. Comparison of hyaluronic acid-containing topical eye drops with carbomer-based topical ocular gel as a tear replacement in canine keratoconjunctivitis sicca: A prospective study in twenty five dogs.
Williams D; Middleton S; Fattahian H; Moridpour R
Vet Res Forum; 2012; 3(4):229-32. PubMed ID: 25653763
[TBL] [Abstract][Full Text] [Related]
20. The effect of topical pimecrolimus on keratoconjunctivitis sicca and chronic superficial keratitis in dogs: results from an exploratory study.
Nell B; Walde I; Billich A; Vit P; Meingassner JG
Vet Ophthalmol; 2005; 8(1):39-46. PubMed ID: 15644099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
